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Summary.-This paper gives the incidence in the Birmingham Regional Cancer
Registry (England) of a second primary tumour in the contralateral breast among
nearly22,000 patients registered with a first primary in the breast between the years
1936 and 1964. The results, based on more than 90,000 woman-years at risk and 399
second primary tumours, are presented with reference to 2 methods of analysis.
In assessing risk, the principal factors investigated were age at first and second
primary diagnoses and the interval between diagnoses. The results are discussed in
terms of current aetiological hypotheses.
On the basis of a method which included coincidental tumours, the overall risk of a
tumour in the contralateral breast was found to be 3*0 times that in the general
population of a first primary. The corresponding risks for 3 main age-ranges
(at the time of diagnosis of the first primary tumour) were 5-6 (ages 15-44 years),
3-7 (45-59 years) and 1-8 (60+ years). When coincidental tumours were excluded from
the analysis, the relative risk was found to be 2-4 overall and 5*3, 3*0 and 1-0 for
the 3 age-ranges, respectively. The level of risk was negatively correlated with
age at first primary and the relative risk remained substantially constant over
time.
DESPITE the extensive literature relat-
ing to the occurrence of bilateral breast
cancer, no firm conclusion about the mag-
nitude ofthe risk ofa new primary tumour
in the contralateral breast can yet be
drawn because, in the main, reports are
based on small selected clinical or necropsy
series for which no general comparative
figures are available. A knowledge ofabso-
lute and differential rates of second pri-
mary tumours is not only of great clinical
importance for the future management of
the breast cancer patient, but might give
some clues to the aetiology of the disease
itself. This paper is concerned with estab-
lishing the incidence of second primary
tumours in the contralateral breast in a
series ofbreast-cancer patients drawn from
a known general population. The relation-
ship between risk and age is also investi-
gated.
Over the years it has become clear that
any reliable estimations must be based on
large quantities ofaccurate data which are
at least representative ofa known popula-
tion. The accepted approach to assessment
now is to select a large series of breast-
cancer patients who have been followed up
for many years, to express their survival
in terms of patient-years at risk, to com-
pute the number of second primary tum-
ours which might be expected to occur
during a pre-set period oftime by applying
age-specific incidence rates to these years
of survival, and to compare the expected
number oftumours with that observed, by
means of suitable tests of significance.
Previous studies
In the following summary of reports
concerning bilateral breast cancer the
above method has been used with someSECOND PRIMARY BREAST CANCERS
modifications and with varying degrees of
comparability, but in each case a serious
attempt has been made to determine ex-
pectations on the basis of incidence rates
for a general population; in each case, a
large series ofpatients was available. Even
so, the risk of a primary tumour in the
opposite breast was found to vary between
.8 and 5 0 times that of a first primary in
the general population.
For a series of over 8000 patients,
registered at the Connecticut Cancer
Record Registry between 1935 and 1951,
an expectation of 51 second primaries was
computed, using State incidence rates for
the relevant years, in comparison with the
observed number of 272. The ratio of
observed to expected was 5.0, but no further
details of methodology were reported
(Ryan et al., 1958).
At the Memorial Hospital, New York,
1458 women treated by radical mastec-
tomy between the years 1940 and 1943
developed 91 second primaries over a 20-
year follow-up. When expectation was
based on rates from the Ten Cities Survey,
the ratio (observed:expected) was found to
be 3*7, whereas State incidence rates for
Connecticut and New York gave values of
4*8 and 5 0 respectively. These figures
clearly underline the importance ofselect-
ing an appropriate general population for
assessment (Robbins and Berg, 1964).
Data from the hospital-based registry of
the Memorial Sloan-Kettering Cancer
Center provided a series of 9792 breast-
cancer patients found over a period of 13
years. On the basis of New York State
-ncidence rates, 55 second primary breast
tumours were expected. Of the 306 cases
observed, 58 (19%) were classified as
synchronous tumours, and for the remain-
ing 248 the ratio (248/55) was 4-5 (Schot-
tenfeld and Berg, 1971).
An apparent ethnic difference was
reported by the Charity Hospital of
Louisiana Tumour Registry; the ratio of
observed to expected numbers was shown
to be 1.8 for white and 3*3 for black
women. Here again the expectations were
based on the Ten Cities Survey which pro-
vided age, site and race-specific rates
(Newell et al., 1974).
Among a seriesof6986patientsadmitted
to the National Cancer Institute ofMilan,
45 women developed synchronous tumours
and 189 consecutive tumours in the oppo-
site breast. Only the latter were com-
pared with the expected number of 598,
the ratio being 3-15. Expectations were
computed from rates supplied by the
Cancer Registry of Piemonte and Valle
d'Aosta (Veronesi et al., 1974).
Background to the Birmingham survey
The investigation presented here forms
part of the Multiple Primary Tumour
Survey undertaken at the Birmingham
Regional Cancer Registry. The Birming-
ham Region comprises 5 counties with a
total population of 5 millions and it is
well-defined geographically and admini-
stratively. Also, covering both urban and
rural areas, itisrepresentative ofthewhole
country.
Registration of cancer cases was started
in the Birmingham Region as far back as
1936, and was extended rapidly to cover
the whole ofthe region. By 1961, the level
of registration was considered to be high
enough (more than 95%) to compute
accurate incidence rates for the regional
population. The results presented here
are, therefore, based on cancer registry
data and, as such, may suffer from some
ofthe disadvantages inherent in any large
body of information (e.g. the multiplicity
of standards for diagnosing, treating,
classifying and reporting tumours). Also,
standards from individual sources change
with time in the light ofknowledge gained
over the years.
Nevertheless, the data available are
population-based. By selecting breast as
the first-primary site, a large series was
obtained, comprising nearly 22,000
patients registered between 1936 and 1964
and followed up regularly thereafter. In
contrast with patients with more deep-
seated tumours, breast cancer patients
experienced a relatively long period of
survival (overall some 42-6% of patients
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survive for 5 years (Waterhouse, 1974))
which allows more chance of observing
second primary tumours. Over a maximal
period of 29 years the loss to follow-up was
less than 10% of all cases. Although for the
purposes of this analysis the period of
observation was terminated in 1965, it is
worth noting that the first four 40-year
survivors were recorded during 1976-77.
For reason of large numbers again,
breast was chosen in the first instance as
the second primary site. In a preliminary
survey of all multiple primary tumours
known to have occurred before the end of
1959, bilateral breast tumours accounted
for 900 of the total, when multiple skin
tumours were excluded.
In the absence of serial histological sec-
tions for every breast tumour, we have
been unable to assess the incidence of
multifocal tumours in the same breast.
The analysis has therefore been limited to
primary tumours in the opposite breast.
This approach is in accordance with
registration procedure; only veryrarely are
2 registrations made for the same breast,
when for example a sarcoma coexists with
a carcinoma.
Starting therefore with a justifiable
degree of confidence in the data, we ven-
tured to hope that the advantages that
accrue from information ofthis quality and
quantity would far outweigh the above
disadvantages.
METHOD AND MATERIALS
Source of data.-The series comprised
21,967 female breast-cancer patients, regis-
tered at the Birmingham Regional Cancer
Registry between 1936 and 1964. The only
exclusions were registrations for the second
primary breast tumour, because these patients
could not be considered to be "at-risk" for
another breast tumour, and another 14 cases,
for whom the age at first diagnosis was
unknown, which were excluded because they
could not be admitted to the age-specific com-
putations. The overall estimation of risk
for a second primary tumour in breast, there-
fore, refers to a total population of breast-
cancer patients and not to a selected sample.
Data processing. Data for all patients
were held primarily on punched cards. Taking
the 1965 anniversary date of their entry as
the closing point to the survey, all cards
were updated to this time or to death if this
occurred earlier. The records wAere then trans-
ferred to magnetic tape and finally to a
computer file store for more rapid access.
Level of tracing. Follow-up information
wvas incomplete for only 165 patients (0.7500
or 1 patient per 545 patient-years), half of
these being registered during 1936-1950, a
period (covering the war years) when tracing
was a little more difficult. Nevertheless, some
of these cases are even now being recovered
through death certificate notifications. For
this reason, many of the later registrations
with only 1 or 2 years of observation missing
are not considered irrevocably lost to the
survey.
In the case of a patient not traced to the
requisite closing date of the survey, survival
was taken up to the last year that she was
known to be alive.
Person-years at risk. The survival experi-
enced by the series was expressed as a two-
dimensional array of person-years at risk in
terms of age-group at, and years of survival
from, the time of first primary diagnosis, up
to a maximum of 29 years.
Incidence rate. Age-specific incidence rates
for breast cancer were computed from the
mean number of breast registrations for the
Birmingham Region between 1960 and 1962,
together with population figures for the
Region obtained from the Registrar General's
1961 Population Census.
Expected number. The general approach
to the computation of expected numbers was
as follows: linear interpolation between the
age-specific incidence rates for breast cancer
for 5-year age-groups was carried out to give
an incidence rate for individual years of age.
The rates were then applied to the appro-
priate yearly elements of the array of person-
years at risk, and the expected number of
second primary breast tumours to occur
during the period of observation, was com-
puted. Modifications to this general approach
are described in more detail below.
Observed number.-The second primary
tumours which developed in the series
within the defined period were ascertained
by searching the Registry's files meticulously,
not'-only for directly linked records, but also
for those cases for whom there was any
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reference to malignancy in or treatment to the
opposite breast. The clinical records for all
these patients were then reassessed to
confirm their eligibility for inclusion in the
survey. Apart from those cases excluded for
clinical reasons (see below), more than
100 other cases were not included because
either the first primary was not registered in
the Birmingham region (and in consequence
the patient was not represented in the years
at risk) or because the diagnosis of either
primary fell outside the time limits of the
period of observation. Second primary
tumours diagnosed outside the region, but
within the prescribed time limits, were
included in the analysis, because such patients
contributed to the expected numbers of
tumours.
Clinical criteria.-One disadvantage in
selecting paired organs for this type ofsurvey
is that difficulty might be experienced in
assessing the status of the second growth.
The tumours may occur close together in
time and, arising in the same type of tissue,
they may be of similar histology. For these
sites, therefore, the criteria used to assess the
primary status of tumours to be included in
the survey must be applied rigorously.
In the simplest situation, each breast would
show a discrete tumour with or writhout
extension to the ipsilateral axillary nodes.
If, however, distant metastases wrere present
either before or at the time ofdiagnosis ofthe
second growth, the latter was not included
as a second primary. Thus, among definite
bases for exclusions were: fixed axillary nodes
at the time of the first tumour; positive
supraclavicular nodes; and skin nodules or
distant metastases discovered before or at the
same time as the second tumour. Subsequent
tumours in the inner quadrant or in the
axillary tail were only included with extreme
caution. Even so, it may be that some
inetastatic tumours have been included
inadvertently, but they would be offset to
some extent by those cases for which the first
tumour, or possibly both tumours, wvere at an
advanced stage when the patient was first
examined, and were therefore excluded on the
basis of the clinical criteria, but which might
in fact have been separate primaries.
In addition to the clinical picture, histo-
logical reports were available for 9300 of
first primary tumours and 870 of second
tumours. In the early years of the Registry,
copies of pathology reports were not always
forthcoming, but after 1953 histological slides
were reviewed centrally by one pathologist
to confirm the diagnosis before registration.
W;;hen no histological report was available,
such as when the only treatment wAas by radio-
therapy or hormones, the case was included
if the clinical criteria were satisfied. In
addition, the opinion of the reporting clini-
cian and also the general clinical picture was
considered (e.g., radical treatment may have
been withheld for reasons of age or con-
current disease). If insufficient information
wNas available the case was excluded. All
cases were, how^rever, reviewed centrally by
one consultant, and the intention throughout
was to err in the direction of discretion rather
than exaggeration so that the results would
represent real effects.
Statistical significance levels.-On the basis
that second primary tumours are relatively
rare events in time, the Poisson distribution
has been used to determine the significance of
the difference between observed and expected
numbers of second primary tumours. Taking
the expected number as the mean of the
distribution, the probability of the observed
number or more occurring by chance was
computed. When combining sub-groups, for
means greater than 50 the significance was
determined from the Normal Deviate, on the
assumption that, for means of this order, the
Poisson can be sufficiently represented by the
Normal distribution with variance equal to
the mean. The results are presented in terms
of the three conventional levels of signifi-
cance.
Coincidental tumaours.- A further problem
in methodology wras posed by the cluster of
coincidental (or synchronous) tumours, which
comprised 23% of all the observed cases. In
the Birmingham survey, they were defined
as those tumours diagnosed at the same time
as, or within one month of, the first primary.
The question was whether or not they were
statistically valid inclusions in the observed
number ofthe analysis. In published surveys,
the statistical treatment of these tumours
has been varied. For the purposes of compari-
son, therefore, the results of this survey
will be presented here in 2 ways: Method 1
includes all the coincidental tumours in the
observed number, leaving expectation, com-
puted in the conventional wray, unaltered;
Method 2 excludes all coincidental tumours
apart from those which might be attributed
to the first month of the first year of the
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survey, again leaving the expected number
unaltered.
RESULTS
Analysis by Method 1
Overall, 399 cases of a second primary
tumour in the opposite breast were ob-
served in the series, for an expectation of
132, the risk being, therefore, 3 0 times
that of the general population for a first
primary at this site. The result was based
on 91,233 woman-years at risk (WYR),
thus giving an actual incidence of 437/
100,000 WYR, in comparison with an
expectation of 145/100,000 WYR. Because
the period of observation was variable,
namely 1 to 29 years according to the year
of entry into the series, more tumours will
undoubtedly arise in the future, so that
the proportion ofpatients (1 8%0) who have
already developed a second tumour is a
figure of only transient interest whereas,
for this particular series, the 93 coinci-
dental tumours (0o42%) which were ob-
served represent a final evaluation.
Age at first primary diagnosis. Sum-
ming the results over the whole period of
observation, observed and expected num-
bers for individual 5-year age-groups are
displayed in Table I, age at the time of
diagnosis of the first primary being the
point of reference. It can be seen that the
observed tumours are in excess ofexpecta-
tion at a highly significant level (P <
0-001) for patients 20 to 59 years of age
at the time of first primary diagnosis. In
patients over 60 years of age, although
there is still some excess, the levels of
significance are more variable. Fig. 1
shows that relative risk (observed/ex-
pected) is negatively associated with age
at first primary diagnosis.
Menopausal status.-In the absence of
complete data for date of menopause, the
age groups were combined into 3 main
age-ranges, which were selected to cover,
broadly speaking, the phases of meno-
pausal status (viz. premenopausal (15-44
years), perimenopausal (45-59 years) and
postmenopausal (60+ years)). Second pri-
mary tumours were significantly in excess
in each age range, but again, the ratio of
observed to expected number decreased
with age (Table I), the relative risk in the
postmenopausal group being only one-
third that of the premenopausal patients.
TABLE I.-Relative Risk ofa Second Primary Breast Tumour in Relation
to Age at First Primary Diagnosis (Method 1)
Age
0 O/E P range
Prermenopausal
15-44
Perimenopausal
45-59
E 0 O/E P
16 82 95 56 ***
51-25 190 37 ***
***
***
***
***
***
***
***
***
**
***
*
*
Postmenopausal
60+ 63-69 114 1-8 ***
131-76 399 30 ***
t Only 1 patient at risk
E: Expectedinumber of second primary tuimlours. 0: Observed0
Age
group
15-19t
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80--84
85-89
90-94
95-994+
Total
E
0*00
0-01
0-15
0-88
4 09
11 70
18 36
16-37
16 51
17 8:3
16-90
13 -09
9-13
4-62
1 -61
0 37
0-14
0
3
6
9
28
49
79
59
52
33
35
24
10
10
2
0
0
300 0
40 0
10 2
6 9
4-2
4-3
:3 6
3-1
1-9
2 1
1-8
1*1
2 2
1 2
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(Quiiary ate-groups)
FIG. 1.-Relative risk of 2nd primary
breast tumours in relation to age at
diagnosis of the 1st primary tumour in
breast (Method 1).
Interval between diagnoses.-Summing
over age groups, the results have also been
analysed in relation to the interval oftime
between the diagnoses of first and second
primary tumours. They are tabulated by
individual years and also by quinquennia
(Table II). The difference between the
observed number and expectation was
highly significant (P < 0.001) up to Year
4; thereafter, individual values were signi-
ficantly different from expectation but at
varying levels.
In terms of quinquennia, there was a
highly significant (P < 0.001) excess of
tumours in Periods 1, 2 and 3. For Period
4, although the observed number was
nearly double the expectation, the dif-
ference did not reach the 5% level of
significance. A significant (P < 0.05) ex-
cess was again found in Period 5; no
tumours were observed in the final 4
years.
TABLEII.-Relative Risk of a SecondPrimary Breast Tumour in Relation to Interval
Between First and Second Primary Diagnoses (Method 1)
Annual
E 0 O/E
P
27-16
20 -24
15-59
12-33
9 94
8-07
6-59
5-32
4-37
3 -73
3-18
2-71
2-32
1 -94
1 -61
1 -32
1*11
0 93
0 77
0-60
0-48
0 39
0-31
0-23
0-19
0-14
0-10
0 06
0 03
146
54
56
27
18
21
11
11
12
4
9
6
3
2
6
1
2
1
1
3
4
1
0
0
0
0
0
0
0
5-4
2-7
3-6
2 -2
1-8
2 -6
1 -7
2-1
2-7
1.1
2-8
2-2
1 -3
1.0
3.7
0-8
1 -8
1 *1
1 3
5 0
8-3
2-6
**
***
**
***
T
***
**
*4*
Quinquennial
E 0 O/E P
85 26
28-08
11 -76
4-73
1-60
0 33
301 3.5 ***
59 2 1
26 2.2 ***
8 1P7
5 3.1
0
131-76 399 30 ***
625
Interval
(years
from 1st
primary)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Total
0.1
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NUMBER of TUMOURS Interval between diagnosis in relation to
acge at first primary. The overall result
presented above does, however, represent
an aggregation of effects for all age-groups
and, when observed and expected num-
bers are broken down to the 3 age-ranges,
differences in the pattern of diagnostic
interval become apparent. Figs. 3(a), (b)
NUMBER of TUMOURS (Method I)
0-5
0-1
20-0
10-0
5-0
2 4 6 8 10 12 14 16 18 20 22 24 26 28
YEARS from Ist PRIMARY DIAGNOSIS
FIG. 2. Observed ( -, 3-point moviing
average) ancd expecteCl (-) numbers of
2nd primary breast tumouirs by year from
1st primary (liagnosis. (Method 1).
Fig. 2 displays these results in the form
of a graph. The observed numbers are
drawn as a 3-point moving average to
allow for the meaningful comparison
between integer (observed number) and
real (expected number) values. In spite of
the apparent peak in observed risk at
about 20 years, the line for observed
numbers shows essentially the same rate
offall as that for expected numbers (bo
-0-084, bE 0-083, s.e. (Diff.)
0-0063, P > 0 05). When the breast-cancer
population is viewed as a whole, the rela-
tive risk appears constant over time and is
2-4 times that for the general population.
Although the 3-point moving average
smoothed many of the irregularities, the
peak at 20 years was not eliminated.
Although the point lies outside the 9500
confidence limits of the observed regres-
sion line and is significantly in excess of
expectation, more data for this period will
be required to ensure that the peak is not
an artefact of small numbers or of follow-
up procedures which highlight periods of
5, 10, 15 and 20 years.
1.0
0-5
YEARS from lst PRIMARY DIAGNOSIS
Fig. 3(a)
NUMBER of TUMOURS (Method )
10-0
5-0
1-0
0-5
U.11
N%
2 4 6 8 10 12 14 16 18 20 22 24 26
YEARS from ost PRIMARY DIAGNOSIS
Fig. 3(b)
1000
500
10-0
5-0
1*-
*~~~~ ~ ~*-
. AA.**
* * *
s - s s * s s s X X X X \ s
e
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NUMBER of TUMOURS (Method I)
30-0
10-0
5-0
1.0
0-5
0.1
0 2 4 6 8 10 12 14 16 18 20 22
YEARS from Ist PRIMARY OfAGNOSIS
Fig. 3(c)
FI(ot. 3. Observed (--, 3-p)Oilt mov'ilng
average) and expected ( ) number of
2nd(I primary breast tumours by year from
1st primary diagnosis for the 3 age-ranges:
(a). 15-44 years, (b). 45-59 years, (c). 60+
years. (Methodl 1).
and (c) present the results for these groups,
with the observed number again shown as a
3-point moving average, to demonstrate
more clearly the trend in the development
of second primary tumours.
Premenopausal group. Atthebeginning
of the period, it can be seen (Fig. 3(a)) that
the observed number is 10 times expecta-
tion, but the excess decreases until, at
about Year 12, it is close to expectation.
There is some evidence of a later peak at
Year 16, but the numbers involved by this
time are very small. Regression analysis
suggests that the risk is falling over time
for this group (bo- 0098, bE 0 054,
s.e. (Diff.) = 0-0077, P < 0.001).
Perimenopausal group. Although thle
general pattern for this group (Fig. 3(b))
is similar to that of the younger patients,
the observed risk at the start ofthe survey
is only 4-5 times expectation and falls
more slowly, reaching expectation at Year
17. For this group, the peak at about 20
years is more pronounced, although again
the numbers involved are small and regres-
sion analysis indicates a constant relative
risk (bo 0-072, bE -0 075, s.e. (Diff.)
0 0084, P not significant).
Postmenopausal group. Initially, the
observed number for this group is twice
expectation (Fig. 3C). In subsequent years
it follows the expected value more closely,
although always lying above it, giving an
overall relative risk of 1P8. For this group
a small divergence of the regression lines
over time was observed (bo - 0-094, bE
0-105, s.e. (Diff.) =0005, P < 0.05).
Although the picture of constant rela-
tive risk for the whole series is an accept-
able mathematical result ofthe parallelism
shown in Fig. 2, it is compounded from
differing patterns for the three age-ranges.
Age at second primary diagnosis.-
Previous reports (Watson, 1953; Schoen-
berg, GCreenberg and Eisenberg, 1969)
grouped the woman-years at risk in terms
of age-specific experience (forfeiting in the
process the factor of "age at first pri-
mary"). When the data for the Birming-
ham survey were re-grouped in a similar
way, it was shown (Fig. 4) that the second
primary occurred at a relatively early age
(median age 59 years) compared with
expectation (median age 67 5 years).
Using the same technique it was pos-
sible to construct an age-specific incidence
rate of secondary primary tumours in the
cancer population, which has been com-
pared with the rate of first primary breast
cancer in the general population in Fig. 5.
There would appear to be a change in
slope around the age of 45 years, similar
but in the opposite direction to that of
first primaries.
Analysis by Method 2
Method 2 was adopted mainly to allow
for comparison with other published series
which excluded coincidental tumours from
their analyses. Basically, the approach
was to repeat all the computations de-
scribed under Method 1, but with the
coincidental tumours removed from the
original observed number. It would follow,
from our definition of coincidental tum-
ours, that some tumours which could be
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FIG. 4.-Observed and expected numbers and relative risk of 2nd primary breast tumours in
relation to age at 2nd primary diagnosis (Method 1).
ascribed to the first month of the survey
would have been eliminated with those
diagnosed at the same time as the first
primary. When cumulative numbers of
observed tumours were plotted by month
for the first year, it was found that a linear
graph was obtained (Fig. 6) so by taking
the mean number per month during the
interval 0 years 1 month and 0 years 11
months, a value for the first month (0
years 0 months) was estimated. The 4
tumours which were included for the first
month were allocated to age-groups 40-44,
45-49, 50-54, 55-59, onthe basisofnearest
integer.
Age atfirstprimarydiagnosis.-TableIII
displays the results given by this method
for 5-year age-groups, and shows that
below the age of 60 years the observed
number of tumours is still in excess of
expectation at a highly significant level
(P < 0.001). In contrast to Method 1, for
patients aged 60 years or more, only one
group (65-69 years) shows a significant
100*0
50@0
10*0
5.0
0*5
0.1
0-05
0*01
0*005
0*001 I & a m a a m a m-
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result (P < 0.05). For the pre- and peri-
menopausal age-ranges the order of signi-
ficance (P < 0 001)isunchanged, although
the relative risk is reduced. But for the
postmenopausal patients, the overall rela-
AGE-SPECIFIC
INCIDENCE RATE.
(Method 1)
tive risk is now 10 (i.e. the observed
number is close to expectation).
A comparison between Methods 1 and 2
for relative risk, by age at first primary
diagnosis (Fig. 7), shows again that the
main differences lie in the results for the
postmenopausal patients.
Interval between diagnoses.-Adjust-
ment ofthe observed number by Method 2
changes the result ofthe analysis in terms
1000-e
500-C
100.C
s0.a
10-0
5-0
150
140
130
120
I
o. _ - v.
_. _-
I
I
110
100
90
10
I
I
I
I
I
20 30 40 50 60 70 00 6C 20 30 40 so 60 70 so 9C
AGE (MEAN for QUINARY AGE-GROUPS)
FIG. 5.-Age-specific incidence rates (N/105
WYR) of 2nd primary tumours ( ) in
comparison with those for 1st primary
breast tumours ( --) (Method 1).
01
,CUMULATIVE NUMBER of
20d PRIMARY TUMOURS
0~
#10
0/
e/
.,0
/ 0
I
2 4 6 a 10
MONTHS from Ist. PRIMARY DIAGNOSIS
FIG. 6.-Cumulative observed number of 2nd
primary breast tumours diagnosed during
the 1st year of observation.
TABLE III.-Relative Risk ofaSecondPrimary Tumour in Breast in Relation
to Age atFirstPrimary (Method 2)
P E 0 O/E P
*
Premenopausal
16-82 89
Perimenopausal
51-25 155
Postmenopausal
63 - 69 66
131-76 310
5.3 ***
30 ***
1.0
2 -4
629
0 O/E
Age
group
15-19t
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85-89
90-94
95+
Total
E
000
0a01
0-15
0-88
4 09
11 70
18-36
16-37
16-51
17-83
16-90
13 -09
9-13
4*62
1 -61
0 37
0-14
0
1
5
9
27
47
66
52
37
18
25
14
2
7
0
0
0
100*0
33-3
10-2
6-6
4-0
3 -6
3 -2
2 -2
1*1
1 -5
1-1
0-2
1 -5
1.0
0
* s
r
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FIG. 7.-Comparison between Method 1 and
Method 2 for relative risk in terms of age at
1st primary.
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FIG. 8. Comparison between Method 1 and 2 for
relative risk in terms of age at 2nd primary.
ofinterval between diagnoses in 3 details:
the relative risks for
(i) the first year = 57/27-16 = 2*1
(ii) thefirst quinquennium - 212/85-26
- 2-5
(iii) overall - 310/131.76 2*4.
In all other respects the results given in
Table II remain the same for each method
of analysis.
Age at second primary diagnosis.-
Exclusion of the coincidental tumours
from this analysis reduced the risk at each
age, but before the age of 60 years the risk
remained significantly high. After age 60,
the observed number approached expecta-
tion more closely. The analyses for Method
1 and 2 are compared in Fig. 8.
DISCUSSION
Methodology
A substantial series ofpatients, followed
for many years, is required to establish the
absolute risk of second primary tumours.
Even so, a large quantity ofdata does not
necessarily ensure freedom from bias, for
example patients drawn from one locality
may be markedly different in many
respects from the totality of cancer
patients in contiguous areas.
Valid comparisons between individual
series are also difficult to make because,
apart from hospital selection which could
introduce bias due to socio-economic
status, ethnic origin, occupation or even
the type oftreatment required, each series
will start with differing age distributions
and will experience varying periods of
observation and patterns of mortality.
Final results will reflect such variation,
whether they are presented in terms of
percentage or as numbers of tumours per
105 person years at risk. For example, a
large series followed for only 5 years could
show adifferent level ofriskfrom a smaller
series followed for 20 years, although the
number ofWYR might be the sameineach
instance.
Even when the more sophisticated
approach to analysis is used (computing
100-0
50s0
10-0
5-0
1-0
0.5
0-1
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expected numbers of tumours) where age-
specific risks might be expected to bear
comparison, the validity of many results
is in doubt for want of reliable or relevant
incidence rates for a general population.
The level of registration of cases in the
region is the most important factor affect-
ing the accuracy ofthe incidence rates, and
hence of the computed expected numbers
in this analysis. Completeness of registra-
tion is not easy to assess, but by the 1 960s
it was considered to be in excess of 9500
(Waterhouse, 1974). The main file of the
Registry is not, however, a static record;
additions and deletions are made when-
ever more accurate information comes to
hand. An attempt was made, therefore,
to estimate the accuracy of the computed
number of 131-7 tumours that might be
expected to occur in the opposite breast.
Recalculating the age-specific incidence
rates for breast on data revised up to
1970, the expected number was found to
be increased to 134 3. This difference
(2.0%) did not, however, alter the levels
of significance, either overall or for indivi-
dual age-groups. It would, of course, be
possible to compute rates using more than
3 years' registrations, but the further one
moves from the census year of 1961, the
more unreliable the population figure
becomes as a denominator.
Cases lost to follow-up could also add to
the inaccuracy ofthe method, but the rate
was very low (<1%) in our series. More-
over, such eases only contribute to the
expected number while they are known to
be alive.
The main area ofuncertainty, therefore,
lies in identifying the second primary
tumours. Definitive diagnosis of multiple
primary tumours in general is a difficult
field, and for paired organs the problems
are greater. But every case was very
thoroughly scrutinized with the aid of an
experienced clinician, working to agreed
standards (see Clinical criteria). In the
absence ofserial sections for every affected
breast, however, we cannot claim infal-
libility, either in detecting every second
primary or in excluding every metastatic
growth, but it is hoped that the resultant
patterns of incidence support a consistent
assessment over the years.
Because of these difficulties, the ob-
served number was limited to those cases
with a first tumour at an early stage, thus
introducing, perhaps, some bias in the
direction of a small under-estimation of
the risk.
When considering the risk of a tumour
in the opposite breast, a point of debate
arises over the validity of using the full
incidence rate for computing expected
numbers of tumours. It could, on the one
hand, be considered that if any breast
tissue remains, it is at the same risk as that
in the intact patient. In this case, the full
breast-cancer rate should be used to com-
pute expected numbers. On the other
hand, it would be possible to consider the
2 breasts as separate sites. Because
right- and left-sided breast tumours occur
with nearly equal frequency, the risk for
one breast alone might therefore be con-
sidered to be half the full rate. In effect
this would be equivalent to computing
the rate in terms of "breasts" rather than
of individuals.
However, one source ofinaccuracy could
arise when using "breasts" as the denomi-
nator: considering the years 1960-62 which
were used to compute the rate, there would
be many women "'at risk" with only one
breast who had undergone mastectomy
before 1960, so that to arrive at the correct
rate it would be necessary to know the
prevalence of women in the population
with only one breast. Although an attempt
to assess the prevalence of women with a
previous mastectomy has been made, it
is very difficult to make an accurate
evaluation. Using it, however, to obtain
the incidence rate per breast gave results
close to those obtained by a straight-
forwaird halving of the full incidence rate
(the rate per wom=an).
Although it is theoretically possible to
compute in terms of "breasts", the appli-
cation of this approach to other sites is
formidable: the concept of computation
in terms of "centimetres of colon" or
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''square centimetres of skin" verges on the
absurd. In the interests of consistency
throughout the survey, then, the "tissue
risk" approach would appear the more
rational and in consequence the full rates
have been used to compute the expected
numbers.
There are some circumstances, however,
when it might be possible to reconcile the
2 concepts. Taking breast again as the
example: ifthe risk ofa breast cancer at a
given age was given as 1 in 1000 indivi-
duals, the risk of a tumour in either breast
would be 1 in 2000 breasts. From this it
could be inferred that a woman with only
one breast would have half the risk of the
intact individual. Nevertheless, the risk is
derived, theoretically at least, from rates
in the intact individual. If, however, the
malignant process is the result of a tissue-
specific carcinogen, the presence of one
breast may modify the risk in the other,
possibly by taking up and neutralizing a
certain proportion ofthe carcinogen. Thus,
although halving therisk might be statisti-
cally acceptable, it may not fit with the
biological situation. With a constant car-
cinogenic challenge the biological risk
might even be doubled in the remaining
breast, owing to the loss of neutralizing
capacity, the net result being that the risk
in that remaining breast would then be
the same as that in the intact individual.
Without further knowledge of the very
complex processes of carcinogenesis, a
resolution of the statistical problem may
not be possible. The effect of halving the
incidence rate would be to halve the
expected number and, thus, to double all
the ratios presented in this paper, a pro-
cedure which would also greatly increase
the statistical-significance indices through-
out. In a situation of uncertainty con-
cerning the correct rationale, we feel that
the use of conservative estimates is the
sounder policy.
Comparisons with published reports
In comparison with other surveys, the
overall value for relative risk of 2-6 pre-
sented here may appear low. It is, how-
ever, based on an unselected series of
patients drawn from a well-defined region
for which tumour incidence rates are
available.
Sofar, 18% ofthe series have developed
a second primary, which also appears low
in comparison with other reports, which
give incidence rates between 1.4% and
12% ofthe initial series. These values will,
however, depend on the criteria for selec-
tion and on the length of the period of
observation. The proportion of coinci-
dental tumours in our series (0.4%) falls
within the reported range (0.1%-2.0%)
but, again, the clinical criteria for defining
second primaries (in particular, coinci-
dental tumours) varies enormously be-
tween series.
Because of the strong relationship be-
tween risk and age at first primary
diagnosis, variation in the initial age dis-
tributions ofindividual series presents the
greatest obstacle to comparison; if the
series is biased towards younger women
the overall riskwill be comparatively high.
Table IV shows a comparison, for initial
age distribution, between (a) the Birming-
ham series, (b) later Birmingham registra-
tions,(c)theMemorialHospital(NewYork)
series and (d) the series from the National
Cancer Institute (Milan). The proportion
of older women is clearly greater in the
Birmingham series than in either the New
York or Milan series.
Comparing the Birmingham series (a)
with later registrations (b), it can be seen
that there has been a further shift of 4%
towards older women. This difference
reflects an improvement in registration of
these cases, as well as ageing of the
population over the years.
An attempt has been made to compare
our results using Method 2 (excluding
coincidental tumours) with those from
Milan (Table V) with reference to the 3
age-ranges. Not only is the ratio greater
overall for the Italian series, as predicted,
but also for each of the 3 age-ranges, a
result which was not necessarily inevit-
able; agreement within age-ranges could
have been obtained at the same time as an
632SECOND PRIMARY BREAST CANCERS
TABLE IV.-Comparative Age Distributions at First Primary Diagnosis
Years of registration
Age < 60 years
Age 60+ years
* Present report.
Centre
Memorial National Cancer
Regional Cancer Registry Hospital Institute
(Birmingham)* (New York)t (Milan)T
(a) 1936-64 (b) 1964-69 (c) 1940-1942 (d) 1928-1956
54 80o 510% 70 9% 73-2%
45-2% 49 0% 291O% 2688%
t Robbins and Berg, 1964. + Veronesi et al., 1974.
TABLE V.-Comparison between Results
from Birmingham (Method 2) and Milan
Age at 1st
primary
1 5-44 years
45-59 years
60-+ years
Total
Birmingham
E 0 O/E
16 82 89 5 3
51 25 155 3 0
63 69 66 1 0
131 *76 310 2 4
Ailan
E 0
4 80 42
26 07 92
28 96 55
59 83 189
O/E
8 8
3 5
1 9
3 2
overall difference because of unequal dis-
tribution of numbers between age-ranges.
The only comparison which can be made
with the New York series is for overall
risk, with the coincidental tumours in-
cluded in the observed number (Method 1),
and this is displayed in Table VI. For all 3
TABLE VI.-Comparison between Results
fromt Birminghamt (Method 1) and New
York
Relative risk
(all cases)
Birmingham New York*
3:0 (i) 50 (ii) 48 (iii) 3-7
* Expectations basecl oIn incidence rates for:
(i) New York State; (ii) Connecticut; (iii) Ten U.S.
Cities
bases of computation, the New York
series shows a higher relative risk than the
Birmingham series, and these results
clearly underline the necessity of choosing
relevant rates for computing expected
numbers.
Interpretation of results
The major factor of risk to emerge from
the results is undoubtedly age at first
primary diagnosis. This is clearly shown
by the overall results for individual age-
groups and also by the age-specific inci-
dence curve for second primary tumours,
41
where maximum incidence occurs in the
youngest age-group. A peak in incidence
can be attributed to, among other factors,
the exhaustion of a genetically susceptible
population, or to a previous exposure to a
carcinogen on a single occasion or over a
brief period of time (Doll, 1971). The
exponential decrease in risk with age
supports the theory of rapid exhaustion
of a susceptible sub-population. However,
a change in the slope for relative risk can
be seen at about age 45, which would
suggest that either two sub-populations
are involved or that there are 2 main
induction periods for second primary
tumours.
Considering that early pregnancy affects
breast-cancer rates in the 5th and 6th
decades, and late pregnancy and artificial
menopause can influence rates as late as
the 7th and 8th decades, a latent period
of at least 20 years can be inferred. For
patients, then, who develop a first breast
cancer around the age of 30 years, an even
earlier point in time than the immediate
postmenarcheal period for induction must
be sought. Several studies have indicated
that premenopausal patients with a
familial history of the disease have a high
risk of bilateral tumours, so that these
women may form the susceptible sub-
group indicated by our results-suscep-
tible in that they may carry genetic pre-
disposition to the disease or in that they
were exposed in utero to an abnormal
maternal metabolism.
One reason for considering the interval
between diagnoses as a separate factor was
to see whether the variation of risk with
time could be linked to specific events,
such as the menopause or treatment to the
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first primary. On inspection it was found
that the cases contributing to the small
peak at 16 years in the premenopausal
group did fall within a very narrow age-
range (55-59 years) in contrast with the
peak in the perimenopausal group which
did not correlate with age at second
primary.
The reality ofthe peak could be justified
on mathematical grounds. The observed
number was significantly in excess of ex-
pectation and also diverged significantly
from the regression line for observed
numbers. It would be of great interest if
tumours occurring at this time could be
shown to be late sequelae of treatment to
the first primary, but with the data at
present available we are unable to test
this hypothesis. The possibility of in-
creased risk at 20 years is not without
precedent, however. Results from long-
term follow-up of another series (Adair et
al., 1974) also showed a higher risk in the
4th quinquennium of the survey. Also of
interest in this context is the report of an
excess of breast cancer in women treated
by radiotherapy for mastitis (Mettler et
al., 1969).
The incidence-rate curve describes the
level of risk in the total breast-cancer
population at specific ages, but there will
be some underestimates after about 70
years, because the contribution from the
original pre- and peri-menopausal groups
to the latter part of the curve is very
small. The apparent fall in risk with age
is due to the addition, at each point, of
increasing numbers of new cases with a
lower risk.
In general, however, the pattern is one
of constant relative risk over time, at a
level determined principally by age at
first primary and which is maintained in
long survivors. The overall result of 399
second primaries in 22,000 women over
nearly 30 years ofobservation confirms the
contraindication of universal prophylactic
bilateral mastectomy, but the picture of
constant relative risk underlines the
importance of continuing and frequent
surveillance.
The Birmingham Multiple Primary Malignant
Tumour Survey is supported by the Cancer Research
Campaign.
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